RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-4.3%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$4.4B
AUM Growth
+$4.4B
(-23%)
Cap. Flow
-$286M
Cap. Flow
% of AUM
-6.51%
Top 10 Holdings %
Top 10 Hldgs %
53.32%
Holding
82
New
7
Increased
5
Reduced
49
Closed
11
Top Buys
| 1 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$247M |
| 2 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
$45.3M |
| 3 |
Entrada Therapeutics
TRDA
|
$33.5M |
| 4 |
Centene
CNC
|
$29.8M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$25.1M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$97.2M |
| 2 |
argenx
ARGX
|
$73.2M |
| 3 |
The Beauty Health Co
SKIN
|
$58M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$34M |
| 5 |
Celldex Therapeutics
CLDX
|
$33.9M |
Sector Composition
| 1 | Healthcare | 94.86% |
| 2 | Consumer Staples | 2.79% |
| 3 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ICU Medical
ICUI
$3.03B
| $52.2M | 1.19% |
219,926
-2,600
| -1% | -$617K |
|
27
Elevance Health
ELV
$72.4B
| $51.1M | 1.16% |
110,289
-17,213
| -14% | -$7.98M |
|
|
SLGC
28
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $48.2M | 1.1% |
4,142,770
+170,500
| +4% | +$1.98M |
|
29
Shattuck Labs
STTK
$61.3M
| $47.8M | 1.09% |
5,619,914
| – | – |
|
|
AUGX
30
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $45.3M | 1.03% |
+14,380,327
| New | +$45.3M |
|
|
GRTS
31
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $44.1M | 1% |
3,429,171
+608,086
| +22% | +$7.82M |
|
32
Pliant Therapeutics
PLRX
$103M
| $41.6M | 0.95% |
3,083,501
| – | – |
|
|
OSH
33
DELISTED
Oak Street Health, Inc.
OSH
| $39.9M | 0.91% |
1,203,619
-674,901
| -36% | -$22.4M |
|
34
Prothena Corp
PRTA
$446M
| $37.8M | 0.86% |
765,675
-135,816
| -15% | -$6.71M |
|
35
Annexon
ANNX
$229M
| $37.1M | 0.84% |
3,228,917
-120,268
| -4% | -$1.38M |
|
36
Akero Therapeutics
AKRO
$3.62B
| $33.9M | 0.77% |
1,602,285
-1,085,159
| -40% | -$23M |
|
|
37
Entrada Therapeutics
TRDA
$202M
| $33.5M | 0.76% |
+1,954,420
| New | +$33.5M |
|
38
Nuvation Bio
NUVB
$1.04B
| $31.2M | 0.71% |
3,671,009
-870,000
| -19% | -$7.4M |
|
|
39
Centene
CNC
$14.6B
| $29.8M | 0.68% |
+361,139
| New | +$29.8M |
|
40
Stevanato
STVN
$6.43B
| $26.3M | 0.6% |
1,170,225
-16,800
| -1% | -$377K |
|
41
Genmab
GMAB
$16.6B
| $26.2M | 0.6% |
661,621
-458,767
| -41% | -$18.1M |
|
|
ISEE
42
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $25.1M | 0.57% |
+1,500,000
| New | +$25.1M |
|
43
The Oncology Institute
TOI
$302M
| $24.4M | 0.55% |
+2,500,000
| New | +$24.4M |
|
44
Immatics
IMTX
$662M
| $23.7M | 0.54% |
1,765,692
-176,200
| -9% | -$2.37M |
|
|
NVRO
45
DELISTED
NEVRO CORP.
NVRO
| $21.9M | 0.5% |
270,116
-272,816
| -50% | -$22.1M |
|
|
ALLK
46
DELISTED
Allakos
ALLK
| $20.3M | 0.46% |
2,077,875
-53,921
| -3% | -$528K |
|
47
Bioventus
BVS
$472M
| $19.2M | 0.44% |
1,325,139
-164,717
| -11% | -$2.39M |
|
48
Neurogene
NGNE
$275M
| $16.8M | 0.38% |
3,490,835
-16,400
| -0.5% | -$79K |
|
49
ALX Oncology
ALXO
$53.6M
| $16.8M | 0.38% |
782,097
-82,338
| -10% | -$1.77M |
|
|
ZGNX
50
DELISTED
Zogenix, Inc.
ZGNX
| $16.2M | 0.37% |
998,114
-16,300
| -2% | -$265K |
|